Clinical Study of U32 in Patients With Acute Myeloid Leukemia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a single-arm, open-label clinical study to evaluate the safety, tolerability, and efficacy of U32 injection in patients with acute myeloid leukemia.
Epistemonikos ID: 6ee105aae0adf69706af60f1ab63225d4f9051d5
First added on: Jun 26, 2025